Episurf Medical to present at Stockholm Corporate Finance Life Science Capital Markets Day on March 8th, 2023

Episurf Medical (Nasdaq: EPIS B) will attend Stockholm Corporate Finance Life Science Capital Markets Day on March 8th, 2023. The event is arranged by Stockholm Corporate Finance and held at IVA konferenscenter in Stockholm. The company will be represented by its CEO Pål Ryfors.

If you want to register as a participant in the capital markets day, please use this link: https://www.lyyti.fi/reg/Stockholm_Corporate_Finance_15e_Life_Science_Seminarium_den_89_mars_2023_6927 The presentation will also be made available afterwards on our website www.episurf.com.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.